Semin intervent Radiol 2018; 35(02): 116-121
DOI: 10.1055/s-0038-1642040
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Patient Assessment: Clinical Presentation, Imaging Diagnosis, Risk Stratification, and the Role of Pulmonary Embolism Response Team

Tamir Friedman
1   Section of Interventional Radiology, Department of Radiology, Advanced Medical Imaging, Torrington, Connecticut
,
Ronald S. Winokur
2   Section of Interventional Radiology, Department of Radiology, Weill Cornell/New York Presbyterian Hospital, New York, New York
,
Keith B. Quencer
3   Section of Interventional Radiology, Department of Radiology, University of Utah, Salt Lake City, Utah
,
David C. Madoff
2   Section of Interventional Radiology, Department of Radiology, Weill Cornell/New York Presbyterian Hospital, New York, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
04 June 2018 (online)

Abstract

Pulmonary embolism (PE) is currently the third leading cause of death and moreover is likely underdiagnosed. PE remains the most common preventable cause of hospital deaths in the United States, which may be attributable to its diagnostic challenges. Although difficult to diagnose, patient mortality rates are time-dependent, and thus, the suspicion and diagnosis of PE in a timely manner is imperative. Diagnosis based on several criteria which may dictate imaging workup as well as laboratory tests and clinical parameters are discussed. The evolution of treatment guidelines via various clinical trials and recommendations is outlined, setting the stage for the use of fibrinolytics, whether systemic or catheter directed. Treatment, including fibrinolytics, is predicated on patient triage into three large categories—massive, submassive, or low-risk PE. Additionally, a relatively new concept of a multidisciplinary team composed of several subspecialty experts known as the PE response team (PERT) is discussed. PERT's timely and unified recommendations have been shown to optimize care and decrease mortality while tailoring treatment to each individual afflicted by PE.

 
  • References

  • 1 Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121 (03) 877-905
  • 2 DeMonaco NA, Dang Q, Kapoor WN, Ragni MV. Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med 2008; 121 (07) 611-617
  • 3 Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation 2005; 112 (02) e28-e32
  • 4 Anderson Jr FA, Wheeler HB, Goldberg RJ. , et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151 (05) 933-938
  • 5 Anderson Jr FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107 (23) (Suppl. 01) I9-I16
  • 6 Rosenberg RD, Aird WC. Vascular-bed--specific hemostasis and hypercoagulable states. N Engl J Med 1999; 340 (20) 1555-1564
  • 7 Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107 (23) (Suppl. 01) I22-I30
  • 8 Cogo A, Lensing AW, Prandoni P, Hirsh J. Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. Arch Intern Med 1993; 153 (24) 2777-2780
  • 9 Stein PD, Beemath A, Matta F. , et al. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med 2007; 120 (10) 871-879
  • 10 Tapson VF. Acute pulmonary embolism. N Engl J Med 2008; 358 (10) 1037-1052
  • 11 Stein PD, Saltzman HA, Weg JG. Clinical characteristics of patients with acute pulmonary embolism. Am J Cardiol 1991; 68 (17) 1723-1724
  • 12 Becattini C, Cohen AT, Agnelli G. , et al. Risk stratification of patients with acute symptomatic pulmonary embolism based on presence or absence of lower extremity DVT: systematic review and meta-analysis. Chest 2016; 149 (01) 192-200
  • 13 Meignan M, Rosso J, Gauthier H. , et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med 2000; 160 (02) 159-164
  • 14 Stein PD, Matta F, Musani MH, Diaczok B. Silent pulmonary embolism in patients with deep venous thrombosis: a systematic review. Am J Med 2010; 123 (05) 426-431
  • 15 Kürkciyan I, Meron G, Sterz F. , et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med 2000; 160 (10) 1529-1535
  • 16 Wicki J, Perneger TV, Junod AF, Bounameaux H, Perrier A. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med 2001; 161 (01) 92-97
  • 17 Chagnon I, Bounameaux H, Aujesky D. , et al. Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism. Am J Med 2002; 113 (04) 269-275
  • 18 Le Gal G, Righini M, Roy P-M. , et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 2006; 144 (03) 165-171
  • 19 Kabrhel C, Camargo Jr CA, Goldhaber SZ. Clinical gestalt and the diagnosis of pulmonary embolism: does experience matter?. Chest 2005; 127 (05) 1627-1630
  • 20 Penaloza A, Verschuren F, Meyer G. , et al. Comparison of the unstructured clinician gestalt, the wells score, and the revised Geneva score to estimate pretest probability for suspected pulmonary embolism. Ann Emerg Med 2013; 62 (02) 117-124.e2
  • 21 Kline JA, Courtney DM, Kabrhel C. , et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost 2008; 6 (05) 772-780
  • 22 Cascade PN. The American College of Radiology. ACR Appropriateness Criteria project. Radiology 2000; 214: 3
  • 23 Bettmann MA, Baginski SG, White RD. , et al. ACR Appropriateness Criteria® acute chest pain--suspected pulmonary embolism. J Thorac Imaging 2012; 27 (02) W28-31
  • 24 Jacobo Kirsch RB, Henry T, Javidan-Nejad C. , et al. American College of Radiology Appropriateness Criteria Suspected Pulmonary Embolism, 2016 Revision. 2016. Available at: https://acsearch.acr.org/docs/69404/Narrative/ . Accessed April 10, 2018
  • 25 Jaff MR, McMurtry MS, Archer SL. , et al; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123 (16) 1788-1830
  • 26 Ghuysen A, Ghaye B, Willems V. , et al. Computed tomographic pulmonary angiography and prognostic significance in patients with acute pulmonary embolism. Thorax 2005; 60 (11) 956-961
  • 27 Schoepf UJ, Kucher N, Kipfmueller F, Quiroz R, Costello P, Goldhaber SZ. Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation 2004; 110 (20) 3276-3280
  • 28 Cahill AG, Stout MJ, Macones GA, Bhalla S. Diagnosing pulmonary embolism in pregnancy using computed-tomographic angiography or ventilation-perfusion. Obstet Gynecol 2009; 114 (01) 124-129
  • 29 Stein PD, Woodard PK, Weg JG. , et al; PIOPED II Investigators. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology 2007; 242 (01) 15-21
  • 30 Revel MP, Cohen S, Sanchez O. , et al. Pulmonary embolism during pregnancy: diagnosis with lung scintigraphy or CT angiography?. Radiology 2011; 258 (02) 590-598
  • 31 Simonneau G, Sors H, Charbonnier B. , et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med 1997; 337 (10) 663-669
  • 32 Martin C, Sobolewski K, Bridgeman P, Boutsikaris D. Systemic thrombolysis for pulmonary embolism: a review. P&T 2016; 41 (12) 770-775
  • 33 Konstantinides S, Torbicki A, Agnelli G. , et al; Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw rozpoznawania i postepowania w ostrej zatorowości płucnej. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism [in Polish]. Kardiol Pol 2014; 72 (11) 997-1053
  • 34 Piazza G. Submassive pulmonary embolism. JAMA 2013; 309 (02) 171-180
  • 35 Piazza G, Hohlfelder B, Jaff MR. , et al; SEATTLE II Investigators. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv 2015; 8 (10) 1382-1392
  • 36 Meyer G, Vicaut E, Danays T. , et al; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014; 370 (15) 1402-1411
  • 37 Torbicki A, Perrier A, Konstantinides S. , et al; ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29 (18) 2276-2315
  • 38 Sista AK, Kearon C. Catheter-directed thrombolysis for pulmonary embolism: where do we stand?. JACC Cardiovasc Interv 2015; 8 (10) 1393-1395
  • 39 Kearon C, Akl EA, Comerota AJ. , et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e419S-e496S
  • 40 Kearon C, Akl EA, Ornelas J. , et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149 (02) 315-352
  • 41 Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. ; Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347 (15) 1143-1150
  • 42 Kline JA, Nordenholz KE, Courtney DM. , et al. Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost 2014; 12 (04) 459-468
  • 43 Becattini C, Agnelli G, Salvi A. , et al; TIPES Study Group. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res 2010; 125 (03) e82-e86
  • 44 Graor RA, Risius B, Lucas FV. , et al. Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft occlusions. Circulation 1986; 74 (3, Pt 2): I15-I20
  • 45 Saxon R, Teigen C. Novel thrombectomy system for below-the-knee and visceral arterial interventions: PRISM retrospective interim results. J Vasc Interv Radiol 2015; 26 (01) 149-150
  • 46 Schrijver AM, de Vries J-PP, van den Heuvel DA, Moll FL. Long-term outcomes of catheter-directed thrombolysis for acute lower extremity occlusions of native arteries and prosthetic bypass grafts. Ann Vasc Surg 2016; 31: 134-142
  • 47 Kucher N, Boekstegers P, Müller OJ. , et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014; 129 (04) 479-486
  • 48 Kuo WT, Banerjee A, Kim PS. , et al. Pulmonary embolism response to fragmentation, embolectomy, and catheter thrombolysis (PERFECT): initial results from a prospective multicenter registry. Chest 2015; 148 (03) 667-673
  • 49 Kabrhel C, Jaff MR, Channick RN, Baker JN, Rosenfield K. A multidisciplinary pulmonary embolism response team. Chest 2013; 144 (05) 1738-1739
  • 50 Dudzinski DM, Piazza G. Multidisciplinary pulmonary embolism response teams. Circulation 2016; 133 (01) 98-103
  • 51 Provias T, Dudzinski DM, Jaff MR. , et al. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract (1995) 2014; 42 (01) 31-37
  • 52 Sista AK, Friedman OA, Dou E. , et al. A pulmonary embolism response team's initial 20 month experience treating 87 patients with submassive and massive pulmonary embolism. Vasc Med 2018; 23 (01) 65-71